Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 11;8(5):421.
doi: 10.3390/biomimetics8050421.

3D-Printed Tumor-on-a-Chip Model for Investigating the Effect of Matrix Stiffness on Glioblastoma Tumor Invasion

Affiliations

3D-Printed Tumor-on-a-Chip Model for Investigating the Effect of Matrix Stiffness on Glioblastoma Tumor Invasion

Meitham Amereh et al. Biomimetics (Basel). .

Abstract

Glioblastoma multiform (GBM) tumor progression has been recognized to be correlated with extracellular matrix (ECM) stiffness. Dynamic variation of tumor ECM is primarily regulated by a family of enzymes which induce remodeling and degradation. In this paper, we investigated the effect of matrix stiffness on the invasion pattern of human glioblastoma tumoroids. A 3D-printed tumor-on-a-chip platform was utilized to culture human glioblastoma tumoroids with the capability of evaluating the effect of stiffness on tumor progression. To induce variations in the stiffness of the collagen matrix, different concentrations of collagenase were added, thereby creating an inhomogeneous collagen concentration. To better understand the mechanisms involved in GBM invasion, an in silico hybrid mathematical model was used to predict the evolution of a tumor in an inhomogeneous environment, providing the ability to study multiple dynamic interacting variables. The model consists of a continuum reaction-diffusion model for the growth of tumoroids and a discrete model to capture the migration of single cells into the surrounding tissue. Results revealed that tumoroids exhibit two distinct patterns of invasion in response to the concentration of collagenase, namely ring-type and finger-type patterns. Moreover, higher concentrations of collagenase resulted in greater invasion lengths, confirming the strong dependency of tumor behavior on the stiffness of the surrounding matrix. The agreement between the experimental results and the model's predictions demonstrates the advantages of this approach in investigating the impact of various extracellular matrix characteristics on tumor growth and invasion.

Keywords: 3D-printing; glioblastoma; in silico model; tumor-on-a-chip.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Optimizing printing variables for horizontal and vertical channels. (a) Image of the Lumen X DLP printer (left), schematic of basic DLP printer in operation (middle), and an example of a CAD model that was used to print vertically oriented channels of different sizes (right). (b) The change in printable channel diameter when a single component is varied in each row, such as LAP concentration, tartrazine concentration, or projector power, from the optimized prepolymer 15% PEGDA solution of 2.04 mM LAP, 2.5 mM tartrazine, 21.5 mW/cm2 power intensity, and 5 s/layer exposure time (left). Microscope images were taken of the sliced cross sections of the PEGDA channel constructs which featured channels with diameters of 1.0, 0.50, 0.40, 0.30, 0.20, and 0.10 mm. Channel cross-sections and top view of vertically printed and horizontally printed PEGDA channels (right). Purple fluorescent dye was injected into the channels to confirm that they were hollow. (c) Graph demonstrating the effects of tartrazine and LAP concentration in 15% PEGDA, 21.5 mW/cm2 power intensity, and 5 s/layer exposure time. When tartrazine concentration was too low, hollow channels could not be printed, as demonstrated in the case of 1 mM tartrazine with 2.04 mM and 3.06 mM LAP (red crosses). (d) Ten channel diameters from 1.0 to 0.1 mm were printed in optimal condition and compared with nominal diameters. Scale bars are 1 mm.
Figure 2
Figure 2
In vitro tumoroid invasion platform. (a) Single cell suspension seeded through the loading zone of a self-filling microwell array. (b) Tumoroids were formed after four days of culture and were transferred into the tumor-on-a-chip platform. (c) The platform was capable of growing tumoroids in four different chambers, each addressed separately, with an inlet and outlet for collagenase treatment. (d) Tumoroids embedded in bovine fibril collagen hydrogel were loaded into the open surface tumoroid-on-a-chip platform and their growth and invasion were monitored over time.
Figure 3
Figure 3
Patterns of hGB invasion. (a) Individual and collective migrations contribute to the invasion patterns. Finger-type pattern is mainly derived from individual cells migrating via mesenchymal motion, and ring-type pattern manifests the collective migration mainly via amoeboid motion. (b) Mechanism of cellular migration includes directional (mesenchymal) and random (amoeboid) motions, which is captured using a hybrid discrete-continuum model (HDC). (c) The model combines modules of cellular processes and random walk with continuum fields of variables, such as cell and nutrient concentrations.
Figure 4
Figure 4
The in vitro invasion of hGB tumoroids. (a) Tumoroids exhibit both ring- and finger-type invasion patterns in response to different concentrations of collagenase; 0 mg/mL (A–C), 0.001 mg/mL (D–F), and 0.01 mg/mL (G–I). (b,c) Effects of collagenase concentration on overall invasion length and invasion pattern are quantified and compared with model predictions (i.e., circles with dashed lines). The inserted figure shows a higher increase in finger-type invasion compared to ring-type invasion length.
Figure 5
Figure 5
Effect of collagenase on mechanical properties of collagen. A decrease in storage and loss moduli was observed in response to 24 h of 0.001 and 0.01 mg/mL collagenase. Further reductions were observed after 72 h of treatment with 0.001 mg/mL of collagenase. Missing results for 72 h of 0.01 mg/mL collagenase is due to the significant degradation of collagen.

Similar articles

Cited by

References

    1. van Solinge T.S., Nieland L., Chiocca E.A., Broekman M.L.D. Advances in local therapy for glioblastoma—Taking the fight to the tumour. Nat. Rev. Neurol. 2022;18:221–236. doi: 10.1038/s41582-022-00621-0. - DOI - PMC - PubMed
    1. Tan A.C., Ashley D.M., López G.Y., Malinzak M., Friedman H.S., Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J. Clin. 2020;70:299–312. doi: 10.3322/caac.21613. - DOI - PubMed
    1. de Gooijer M.C., Navarro M.G., Bernards R., Wurdinger T., van Tellingen O. An experimenter’s guide to glioblastoma invasion pathways. Trends Mol. Med. 2018;24:763–780. doi: 10.1016/j.molmed.2018.07.003. - DOI - PubMed
    1. Vollmann-Zwerenz A., Leidgens V., Feliciello G., Klein C.A., Hau P. Tumor Cell Invasion in Glioblastoma. Int. J. Mol. Sci. 2020;21:1932. doi: 10.3390/ijms21061932. - DOI - PMC - PubMed
    1. Hanahan D., Weinberg R.A. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed

LinkOut - more resources